Local Coverage Determination (LCD): Psychological and Neuropsychological Tests (L34520)

Transcription

1 Local Coverage Determination (LCD): Psychological and Neuropsychological Tests (L34520) Contractor Information Contractor Name First Coast Service Options, Inc. LCD Information Document Information LCD ID L34520 Original ICD-9 LCD ID L33688 LCD Title Psychological and Neuropsychological Tests AMA CPT / ADA CDT / AHA NUBC Copyright Statement CPT only copyright American Medical Association. All Rights Reserved. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Apply to Government Use. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. The Code on Dental Procedures and Nomenclature (Code) is published in Current Original Effective Date For services performed on or after 10/01/2015 Revision Effective Date Revision Ending Date Retirement Date Notice Period Start Date Notice Period End Date

2 Dental Terminology (CDT). Copyright American Dental Association. All rights reserved. CDT and CDT-2010 are trademarks of the American Dental Association. UB-04 Manual. OFFICIAL UB-04 DATA SPECIFICATIONS MANUAL, 2014, is copyrighted by American Hospital Association ( AHA ), Chicago, Illinois. No portion of OFFICIAL UB-04 MANUAL may be reproduced, sorted in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior express, written consent of AHA. Health Forum reserves the right to change the copyright notice from time to time upon written notice to Company. CMS National Coverage Policy Language quoted from CMS National Coverage Determination (NCDs) and coverage provisions in interpretive manuals are italicized throughout the Local Coverage Determination (LCD). NCDs and coverage provisions in interpretive manuals are not subject to the LCD Review Process (42 CFR [b] and 42 CFR 426 [Subpart D]). In addition, an administrative law judge may not review an NCD. See 1869(f)(1)(A)(i) of the Social Security Act. Unless otherwise specified, italicized text represents quotation from one or more of the following CMS sources: CMS Manual System, Pub , Medicare Benefit Policy Manual, Chapter 15, Section 80.2 Psychological Tests and Neuropsychological Tests, and Sections Clinical Psychologists and Clinical Social Worker (CSW) Services CMS Manual System, Pub , Medicare Program Integrity, Chapter 3, Section Psychotherapy Notes CMS Medicare Learning Network, March 2012, Mental Health Services (accessible at: MLN/MLNProducts/downloads/Mental_Health_Services_ICN pdf) National Correct Coding Initiative Policy Manual for Medicare Services NCCI), Chap 11, section M Central Nervous System Assessments/Tests Coverage Guidance Coverage Indications, Limitations, and/or Medical Necessity Neuropsychological tests provide measurements of brain function that are objective, valid, and

3 reliable. Neuropsychological tests are quantifiable in nature and require patients to directly demonstrate their level of cognitive competence in a particular cognitive domain. Neuropsychological tests are administered in the context of a comprehensive assessment that synthesizes data from clinical interview, record review, medical history, and behavioral observations. Information from neuropsychological assessments directly impacts medical management of patients by providing information about diagnosis, prognosis, and treatment of disorders that are known to impact central nervous system (CNS) functioning. In addition, neuropsychological assessments predict functional abilities across a variety of disorders. Indications for neuropsychological assessments include a history of medical or neurological disorder compromising cognitive or behavioral functioning; congenital, genetic, or metabolic disorders known to be associated with impairments in cognitive or brain development; reported impairments in cognitive functioning; and evaluations of cognitive function as a part of the standard of care for treatment selection and treatment outcome evaluations (e.g., deep brain stimulators, epilepsy surgery). Neuropsychological assessments are not limited in relevance to patients with evidence of structural brain damage, and are frequently necessary to document impairments in patients with probable neuropsychological and neurobehavioral disorders, and are the tool of choice whenever objective documentation of subjective cognitive complaints and symptom validity testing are indicated. In children and adolescents, a significant inability to develop expected knowledge, skills or abilities as required to adapt to new or changing cognitive, social, emotional, or physical demands warrants a neuropsychological evaluation. Neuropsychological testing is not supported or excluded from medical necessity based on diagnosis alone. Rather, indications for testing are based on whether there is known or suspected neurocognitive involvement or effects, or where neuropsychological testing will impact the management of the patient by confirmation or delineation of diagnosis, or otherwise providing substantive information regarding diagnosis, treatment planning, prognosis, or quality of life. Neuropsychological testing is useful in persons with documented changes in cognitive function to differentiate neurologic diseases (i.e., one of the types of dementia) or injuries (e.g., traumatic brain injury, stroke) from depressive disorders or other psychiatric conditions (e.g., psychosis, schizophrenia) when the diagnosis is uncertain after complete neurological examination, mental status examination, and other neurodiagnostic studies (e.g., CT scanning, MR imaging). The clinician presented with complaints of memory impairment or slowness in thinking in a patient who is depressed or paranoid may be unsure of the possible contribution of neurological changes to the clinical picture. Neuropsychological testing may be particularly helpful when the findings of the neurological examination and ancillary procedures are either negative or equivocal. The differential diagnosis of incipient dementia from depression is a case in point, particularly when computed tomography (CT) fails to yield definitive results. Neuropsychological testing may be indicated in persons with epilepsy. Neuropsychological testing is used in these patients to monitor the efficacy and possible cognitive side effects of drug therapy (e.g., new anti-convulsant drug therapy) by comparing baseline performance with subsequent testing performance. Neuropsychological testing is also used to assess post-surgical changes in cognitive functioning to guide further treatment services. Preferably, these tests should be administered by a psychiatrist or certified psychologist trained to conceptualize the

4 neuro-anatomical and the neuro-behavioral implications of the diagnostic entities under consideration and who is capable of interpreting patterns of test scores in view of principles of lateralization and localization of cerebral function. Codes 96105, 96111, 96116, 96118, 96119, 96120, and G0451 are defined by their CPT/HCPCS descriptors. Code represents the formal evaluation of aphasia using a psychometric instrument such as the Boston Diagnostic Aphasia Examination. This testing is typically performed once during treatment, and the medical necessity for such testing should be documented. Repeat testing should only be done if there is a significant change in the patient s aphasic condition. Codes 96118, 96119, and describe testing which is intended to diagnose and characterize the neurocognitive effects of medical disorders that impinge directly or indirectly on the brain. Neuropsychological testing is considered medically necessary for the following indications: When there are deficits on standard mental status testing or clinical interview, and a neuropsychological assessment is needed to establish the presence of abnormalities or distinguish them from other disease processes; or When neuropsychological data could provide clarification of clinical, laboratory, and neuroimaging data to assist in establishing a clinical diagnosis in neurological or systemic conditions known to affect CNS functioning; or When there is a need to quantify cognitive or behavioral deficits related to CNS impairment, and the information will be useful in determining a prognosis or treatment planning by determining the rate of disease progression; or When there is a need for a pre-surgical or treatment-related cognitive evaluation to inform whether one might safely proceed with a medical or surgical procedure that may affect brain function (e.g., deep brain stimulation, resection of brain tumors or arteriovenous malformations, epilepsy surgery) or significantly alter a patient s functional status; or When there is a need to assess the potential impact of adverse effects of therapeutic substances that may cause cognitive impairment (e.g., radiation, chemotherapy, antiepileptic medications), and this information is utilized in treatment planning; or When there is a need to assess progression, recovery, and response to changing treatments, in patients with CNS disorders, in order to determine the most effective plan of care; or When there is a need for objective measurement of patients' subjective complaints about memory, attention, or other cognitive dysfunction, which directly impacts medical management by differentiating psychogenic from neurogenic syndromes (e.g., dementia vs. depression), and in some cases will result in initial detection of neurological disorders or systemic diseases affecting the brain; or When there is a need for treatment planning purposes of determining functional abilities/impairments in individuals with known or suspected CNS disorders (e.g., capacity for independent living or movement from a family home into an institutional setting); or

5 When there is a need to determine whether a patient can comprehend and participate effectively in complex treatment regimens and to determine functional capacity for health care decision-making, independent living, etc.; or When there is a need to design, administer, and/or assess outcomes of cognitive rehabilitation procedures, often in collaboration with other specialists such as speech pathologists, occupational therapists, physiatrists, and rehabilitation psychologists; or When there is a need for treatment planning of identification and assessment of neurocognitive sequelae of disease ; or Assessment of neurocognitive functions for the formulation of rehabilitation and/or management strategies for certain individuals with neuropsychiatric disorders; or When there is a need to diagnose cognitive or functional deficits in children and adolescents based on an inability to develop expected knowledge, skills or abilities as required to adapt to new or changing cognitive, social, emotional, or physical demands. The content of neuropsychological testing procedures (96118, 96119, and 96120) differs from that of psychological testing ( and G0451) in that neuropsychological testing consists primarily of individually administered ability tests that comprehensively sample cognitive and performance domains that are known to be sensitive to the functional integrity of the brain (e.g., abstraction, memory and learning, attention, language, problem solving, sensorimotor functions, constructional praxis, etc.). Neuropsychological testing does not rely on self-report questionnaires such as the Minnesota Multiphasic Personality Inventory 2 (MMPI-2), rating scales such as the Hamilton Depression Rating Scale, or projective techniques such as the Rorschach or Thematic Apperception Test (TAT). In circumstances when additional time is necessary to integrate other sources of clinical data including previously completed and reported technician- and/or computer-administered tests, the neuropsychological testing may include time spent integrating self-report questionnaires. Psychological testing codes (96101, 96102, and 96103) include the administration, interpretation, and scoring of the tests mentioned in the CPT descriptors and other medically accepted tests for the evaluation of intellectual strengths, psychopathology, psychodynamics, mental health risks, insight, motivation, and other factors influencing treatment and prognosis. Psychological tests are used to address a variety of questions about people s functioning, diagnostic classification, co-morbidity, and choice of treatment approach. For example, personality tests and inventories evaluate the thoughts, emotions, attitudes, and behavioral traits that contribute to an individual s interpersonal functioning. The results of these tests determine an individual's personality strengths and weaknesses and may identify certain disturbances in personality or psychopathology. One type of personality test is the projective personality assessment, which asks a subject to interpret some ambiguous stimuli, such as a series of inkblots. The subject's responses can provide insight into his or her thought processes and personality traits. Examples of problems that might require psychological testing include:

6 1. Assessment of mental functioning for individuals with suspected or known mental disorders for purposes of differential diagnosis and/or treatment planning. 2. Assessment of patient strengths and disabilities for use in treatment planning or management when signs or symptoms of a mental disorder are present. 3. Assessment of patient capacity for decision-making when impairment is suspected that would affect patient care or management. 4. Assessment of mental function in certain chronic pain patients when indicated after psychological screening prior to surgical pain management intervention (e.g., implantable neurostimulator). 5. Assessment of mental function in a chronic pain patient with suspected somatization disorder. Changes in mental illness may require psychological testing to determine new diagnoses or the need for changes in therapeutic measures. Repeat testing not required for diagnosis or continued treatment would be considered medically unnecessary. Nonspecific behaviors that do not indicate the presence of, or change in, a mental illness would not be an acceptable indication for testing. Psychological or psychiatric evaluations that can be accomplished through the clinical interview alone (e.g., response to medication) would not require psychological testing, and such testing might be considered as medically unnecessary. Adjustment reactions or dysphoria associated with moving to a nursing facility do not constitute medical necessity for psychological testing. When a psychiatric condition or the presence of dementia has already been diagnosed, there is value to the testing only if the information derived from the testing would be expected to have significant impact on the understanding and treatment of the patient. Examples include a significant change in the patient s condition, the need to evaluate a patient s capacity to function in a given situation or environment, and/or the need to specifically tailor therapeutic and/or compensatory techniques to particular aspects of the patient s pattern of strengths and disabilities. Limitations Psychological and Neuropsychological testing is not considered reasonable and necessary when: the patient is not neurologically and cognitively able to participate in a meaningful way in the testing process; administered for educational or vocational purposes that do not establish medical management; performed when abnormalities of brain or emotional function are not suspected; used for self-administered or self-scored inventories or screening tests of cognitive function (paper-and-pencil or computerized), e.g., AIMS, Folstein Mini-Mental Status Examination; Repeated when not required for medical decision-making. Examples of medical decision making include: whether to start or continue a particular rehabilitative or pharmacologic therapy);

7 Administered when the patient has a substance abuse background, and any of the following apply: the patient has ongoing substance abuse such that test results would be inaccurate, or the patient is currently intoxicated; The patient has been diagnosed previously with brain dysfunction, e.g., Alzheimer s disease, and there is no expectation that the testing would impact the patient's medical management; The test is being given solely as a screening test for Alzheimer's disease. This screening is not covered for this diagnosis. Testing conducted when no mental illness/disability is suspected would be considered screening and would not be covered. Non-specific behaviors that do not suggest the possibility of mental illness or disability are not an acceptable indication for testing. Evaluations of the mental status that can be performed within the psychiatric diagnostic evaluation (e.g., codes 90791, 90792), (e.g., a list of questions concerning symptoms of depression or organic brain syndrome, corresponding to brief questionnaires or screening measures such as the Folstein Mini Mental Status Examination or the Beck Depression Scale, or use of other mental status exams in isolation ) should not be classified separately as psychological or neuropsychological testing (codes , G0451) since they are typically part of a more general psychiatric/psychological clinical exam or interview. Psychological/neuropsychological testing to evaluate adjustment reactions or dysphoria associated with placement in a nursing home does not constitute medical necessity for testing. Testing of every patient upon entry to a nursing home would be considered a routine service and would not be covered. However, some individuals enter a nursing home at a time of physical and cognitive decline and may require psychological/neuropsychological testing to arrive at a diagnosis and plan of care. Decisions to test individuals who have recently entered a nursing home need to be made judiciously, on a case-by-case basis. Each psychological/neuropsychological test administered must be individually medically necessary. A standard battery of tests is only medically necessary if each individual test in the battery is medically necessary. The psychological/neuropsychological testing codes should not be reported by the treating physician for only reading the testing report or explaining the results to the patient or family. Payment for these services is included in the payment for other services rendered to the patient, such as evaluation and management services. Psychological and neuropsychological testing codes should be reported by the performing provider (i.e., clinical psychologist, neuropsychologist, or physician) who administered the test. Coding Information

8 Bill Type Codes: Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the policy does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the policy should be assumed to apply equally to all claims. 012x Hospital Inpatient (Medicare Part B only) 013x Hospital Outpatient 022x Skilled Nursing - Inpatient (Medicare Part B only) 023x Skilled Nursing - Outpatient 071x Clinic - Rural Health 075x Clinic - Comprehensive Outpatient Rehabilitation Facility (CORF) 076x Clinic - Community Mental Health Center 077x Clinic - Federally Qualified Health Center (FQHC) 085x Critical Access Hospital Revenue Codes: Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes. Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory; unless specified in the policy services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the policy should be assumed to apply equally to all Revenue Codes Behavioral Health Treatment/Services - Testing CPT/HCPCS Codes Group 1 Paragraph: Group 1 Codes: PSYCHOLOGICAL TESTING (INCLUDES PSYCHODIAGNOSTIC ASSESSMENT OF EMOTIONALITY, INTELLECTUAL ABILITIES, PERSONALITY AND PSYCHOPATHOLOGY, EG, MMPI, RORSCHACH, WAIS), PER HOUR OF THE PSYCHOLOGIST'S OR PHYSICIAN'S TIME, BOTH FACE-TO-FACE TIME

9 ADMINISTERING TESTS TO THE PATIENT AND TIME INTERPRETING THESE TEST RESULTS AND PREPARING THE REPORT PSYCHOLOGICAL TESTING (INCLUDES PSYCHODIAGNOSTIC ASSESSMENT OF EMOTIONALITY, INTELLECTUAL ABILITIES, PERSONALITY AND PSYCHOPATHOLOGY, EG, MMPI AND WAIS), WITH QUALIFIED HEALTH CARE PROFESSIONAL INTERPRETATION AND REPORT, ADMINISTERED BY TECHNICIAN, PER HOUR OF TECHNICIAN TIME, FACE-TO-FACE PSYCHOLOGICAL TESTING (INCLUDES PSYCHODIAGNOSTIC ASSESSMENT OF EMOTIONALITY, INTELLECTUAL ABILITIES, PERSONALITY AND PSYCHOPATHOLOGY, EG, MMPI), ADMINISTERED BY A COMPUTER, WITH QUALIFIED HEALTH CARE PROFESSIONAL INTERPRETATION AND REPORT ASSESSMENT OF APHASIA (INCLUDES ASSESSMENT OF EXPRESSIVE AND RECEPTIVE SPEECH AND LANGUAGE FUNCTION, LANGUAGE COMPREHENSION, SPEECH PRODUCTION ABILITY, READING, SPELLING, WRITING, EG, BY BOSTON DIAGNOSTIC APHASIA EXAMINATION) WITH INTERPRETATION AND REPORT, PER HOUR DEVELOPMENTAL TESTING, (INCLUDES ASSESSMENT OF MOTOR, LANGUAGE, SOCIAL, ADAPTIVE, AND/OR COGNITIVE FUNCTIONING BY STANDARDIZED DEVELOPMENTAL INSTRUMENTS) WITH INTERPRETATION AND REPORT NEUROBEHAVIORAL STATUS EXAM (CLINICAL ASSESSMENT OF THINKING, REASONING AND JUDGMENT, EG, ACQUIRED KNOWLEDGE, ATTENTION, LANGUAGE, MEMORY, PLANNING AND PROBLEM SOLVING, AND VISUAL SPATIAL ABILITIES), PER HOUR OF THE PSYCHOLOGIST'S OR PHYSICIAN'S TIME, BOTH FACE-TO-FACE TIME WITH THE PATIENT AND TIME INTERPRETING TEST RESULTS AND PREPARING THE REPORT NEUROPSYCHOLOGICAL TESTING (EG, HALSTEAD-REITAN NEUROPSYCHOLOGICAL BATTERY, WECHSLER MEMORY SCALES AND WISCONSIN CARD SORTING TEST), PER HOUR OF THE PSYCHOLOGIST'S OR PHYSICIAN'S TIME, BOTH FACE-TO-FACE TIME ADMINISTERING TESTS TO THE PATIENT AND TIME INTERPRETING THESE TEST RESULTS AND PREPARING THE REPORT NEUROPSYCHOLOGICAL TESTING (EG, HALSTEAD-REITAN NEUROPSYCHOLOGICAL BATTERY, WECHSLER MEMORY SCALES AND WISCONSIN CARD SORTING TEST), WITH QUALIFIED HEALTH CARE PROFESSIONAL INTERPRETATION AND REPORT, ADMINISTERED BY TECHNICIAN, PER HOUR OF TECHNICIAN TIME, FACE-TO-FACE NEUROPSYCHOLOGICAL TESTING (EG, WISCONSIN CARD SORTING TEST), ADMINISTERED BY A COMPUTER, WITH QUALIFIED HEALTH CARE PROFESSIONAL INTERPRETATION AND REPORT DEVELOPMENT TESTING, WITH INTERPRETATION AND REPORT, PER G0451 STANDARDIZED INSTRUMENT FORM

10 ICD-10 Codes that Support Medical Necessity Group 1 Paragraph: For CPT/HCPCS codes 96101, 96102, 96103, 96118, 96119, 96120,and G0451 only: Group 1Codes ICD-10 Code Description F F09 - Opens in Vascular dementia without behavioral disturbance - Unspecified mental a new disorder due to known physiological condition F F39 - Opens Alcohol abuse with intoxication, uncomplicated - Unspecified mood [affective] disorder F F Opens Agoraphobia, unspecified - Nonpsychotic mental disorder, unspecified F F59 - Opens in Anorexia nervosa, unspecified - Unspecified behavioral syndromes a new associated with physiological disturbances and physical factors F F69 - Opens in Paranoid personality disorder - Unspecified disorder of adult personality a new and behavior F70 - F79 - Opens in a Mild intellectual disabilities - Unspecified intellectual disabilities new F F82 - Opens in Phonological disorder - Specific developmental disorder of motor a new function F84.0 Autistic disorder F F Opens Other childhood disintegrative disorder - Pervasive developmental disorder, unspecified F88 Other disorders of psychological development F89 Unspecified disorder of psychological development Attention-deficit hyperactivity disorder, predominantly inattentive type - F F Opens Unspecified behavioral and emotional disorders with onset usually occurring in childhood and adolescence F99 Mental disorder, not otherwise specified G G Opens Systemic atrophy primarily affecting the central nervous system in myxedema - Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere G G Opens G G Opens G G Opens in a new G24.2 Idiopathic nonfamilial dystonia G24.4 Idiopathic orofacial dystonia G24.8 Other dystonia Malignant neuroleptic syndrome - Postencephalitic parkinsonism Other secondary parkinsonism - Secondary parkinsonism, unspecified Drug induced subacute dyskinesia - Other drug induced dystonia

11 G G Opens Essential tremor - Other specified forms of tremor G G Drug induced movement disorder, unspecified - Other drug induced Opens in a new movement disorders G25.89 Other specified extrapyramidal and movement disorders G25.9 Extrapyramidal and movement disorder, unspecified G26 Extrapyramidal and movement disorders in diseases classified elsewhere G G Opens Alzheimer's disease with early onset - Alzheimer's disease, unspecified G G Opens in a new Pick's disease - Degeneration of nervous system due to alcohol G G Dementia with Lewy bodies - Other specified degenerative diseases of Opens in a new nervous system G Tension-type headache, unspecified, not intractable G G Opens in a new REM sleep behavior disorder - Recurrent isolated sleep paralysis G80.3 Athetoid cerebral palsy G G Opens Communicating hydrocephalus - Hydrocephalus, unspecified G93.1 Anoxic brain damage, not elsewhere classified G94 Other disorders of brain in diseases classified elsewhere H91.3 Deaf nonspeaking, not elsewhere classified H93.25 Central auditory processing disorder I I Opens Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation - Occlusion and stenosis of unspecified cerebral artery I I Cognitive deficits following nontraumatic subarachnoid hemorrhage - Opens in a new Aphasia following nontraumatic subarachnoid hemorrhage I Dysarthria following nontraumatic subarachnoid hemorrhage I I Cognitive deficits following nontraumatic intracerebral hemorrhage - Opens in a new Dysarthria following nontraumatic intracerebral hemorrhage I69.21 Cognitive deficits following other nontraumatic intracranial hemorrhage I Aphasia following other nontraumatic intracranial hemorrhage I Dysarthria following other nontraumatic intracranial hemorrhage I69.31 Cognitive deficits following cerebral infarction I Aphasia following cerebral infarction I Dysarthria following cerebral infarction I69.81 Cognitive deficits following other cerebrovascular disease

12 I Aphasia following other cerebrovascular disease I Dysarthria following other cerebrovascular disease I69.91 Cognitive deficits following unspecified cerebrovascular disease I Aphasia following unspecified cerebrovascular disease I Dysarthria following unspecified cerebrovascular disease R37 Sexual dysfunction, unspecified R R Opens Somnolence - Stupor R R Opens Disorientation, unspecified - Other amnesia R41.82 Altered mental status, unspecified R R Opens in a new R R Opens Attention and concentration deficit - Other symptoms and signs involving cognitive functions and awareness Restlessness and agitation - Unhappiness R R Opens Hostility - Excessive crying of child, adolescent or adult R47.02 Dysphasia R47.1 Dysarthria and anarthria R47.81 Slurred speech R47.89 Other speech disturbances R47.9 Unspecified speech disturbances R R Opens Dyslexia and alexia - Apraxia R R Opens Other symbolic dysfunctions - Unspecified symbolic dysfunctions S06.0X0A - S06.9X9S Concussion without loss of consciousness, initial encounter - - Opens in a new Unspecified intracranial injury with loss of consciousness of unspecified duration, sequela T50.905A - T50.905S - Opens in a new T74.01XA - T74.92XS - Opens in a new T76.01XA - T76.92XS - Opens in a new Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter - Adverse effect of unspecified drugs, medicaments and biological substances, sequela Adult neglect or abandonment, confirmed, initial encounter - Unspecified child maltreatment, confirmed, sequela Adult neglect or abandonment, suspected, initial encounter - Unspecified child maltreatment, suspected, sequela Z Personal history of sex reassignment Showing 1 to 71 of 71 entries in Group 1

13 ICD-10 Codes that DO NOT Support Medical Necessity Additional ICD-10 Information General Information Associated Information Documentation Requirements The medical record must indicate testing is necessary as an aid in the diagnosis and therapeutic planning. The record must show the tests performed, scoring and interpretation, as well as the time involved for services that are time-based. The medical record should include all of the following information: Reason for referral. Tests administered, scoring/interpretation, and time involved. Present evaluation. Diagnosis (or suspected diagnosis that was the basis for the testing if no mental/neurocognitive illness was found). Recommendations for interventions, if necessary. Identity of person performing service. Utilization Guidelines Typically, psychological testing/neuropsychological testing may require four (4) to six (6) hours to perform (including administration, scoring, and interpretation.) If the testing is done over several days, the testing time should be combined and reported all on the last date of service. Supporting documentation in the medical record must be present to justify the medical necessity and hours tested per patient per evaluation. If the testing time exceeds eight (8) hours, medical necessity for the extended testing should be documented in the report. Use of such tests when mental or neurocognitive illness is not suspected would be a screening procedure and not covered. Each test performed must be medically necessary. Therefore, standardized batteries of tests are not acceptable unless each test in the battery is medically necessary.

14 Routine re-evaluation of chronically disabled patients that is not required for a diagnosis or continued treatment is not medically necessary. Sources of Information and Basis for Decision American Academy of Clinical Neuropsychology (AACN), (October 2011) Neuropsychology Model LCD. Accessed at 1.pdf American Medical Association (2013) CPT Professional Edition CGS Administrators, LLC LCD (L31887) Code of Federal Regulations (CFR) Diagnostic x-ray tests, diagnostic laboratory tests, and other diagnostic tests: Conditions. HCPCS Level II 2013 Book, Professional Edition LCDs and policies from other Medicare contractors and private insurers National Government Services, Inc. LCD (L26895) Novitas Solutions, Inc. LCD (L32766) Wisconsin Physicians Service Insurance Corporation LCD (L31990) Revision History Information Associated Documents Attachments Coding guideline effec 10/1/14 opens in new Related Local Coverage Documents Related National Coverage Documents Public Version(s) Updated on 07/01/2014 with effective dates 10/01/ Updated on 04/01/2014 with effective dates 10/01/2015 -

15 Keywords Read the LCD Disclaimer opens in new FIRST COAST SERVICE OPTIONS MAC - PART A/B CODING GUIDELINES LCD Database ID Number L34520 Contractor Name First Coast Service Options, Inc. Contractor Number Florida Puerto Rico/Virgin Islands Florida Puerto Rico Virgin Islands LCD Title Psychological and Neuropsychological Tests Coding Guidelines CMS Manual System, Pub , Medicare Benefit Policy Manual, Chapter 15, Section Psychological Tests and Neuropsychological Tests: Payment for psychological testing is limited to physicians, clinical psychologists, and on a limited basis, to qualified non-physician practitioners (e.g., speech language pathologists for aphasia evaluation). Independently Practicing Psychologists (IPPs) may bill for psychological and/or neuropsychological tests when the tests are ordered by a physician. Psychological and neuropsychological tests performed by a psychologist (who is not a CP) practicing independently of an institution, agency, or physician s office are covered when a physician orders such tests. An IPP is any psychologist who is licensed or certified to practice psychology in the State or jurisdiction where furnishing services or, if the jurisdiction does not issue licenses, if provided by any practicing psychologist. (It is CMS s understanding that all States, the District of Columbia, and Puerto Rico license psychologists, but that some trust territories do not.

16 Examples of psychologists, other than CPs, whose psychological and neuropsychological tests are covered under the diagnostic tests provision include, but are not limited to, educational psychologists and counseling psychologists.) Medicare does not authorize payment for psychological and neuropsychological testing when performed on an incident to basis. Information derived from psychological and neuropsychological testing is often provided to the patient and other individuals as authorized by the patient. This information includes the results of the evaluation, potential intervention options, and referrals. Time spent providing that feedback as well as receiving any response to that information provided by the patient and/or authorized individuals is coded, using the appropriate number of billing units, with the CPT code for the testing; code (for psychological testing) or code (for neuropsychological testing). However, only communication regarding the testing results and feedback would be coded in this manner; assessment and management of other aspects of the patient's care would be coded using other appropriate CPT coding. Refer to the National Correct Coding Initiative (NCCI) Policy Manual for correct coding guidelines and applicable code combinations prior to billing Medicare. Provisions of an LCD do not take precedence over NCCI edits. *** Physicians must report services correctly. The NCCI Policy Manual for Medicare Service discusses general coding principles and principles more relevant to specific groups of HCPCS/CPT codes. Although the emphasis in the manual is correct coding, there are certain types of improper coding that physicians must avoid. Procedures should be reported with the most comprehensive CPT code that describes the services performed. Physicians must not unbundle the services described by a HCPCS/CPT code. Physicians must avoid upcoding or downcoding and must report units of service correctly. Central Nervous System Assessments/Tests (NCCI Manual, Chapter 11): 1. Neurobehavioral status exam (CPT code 96116) should not be reported when a mini-mental status examination is performed. CPT code should never be reported with psychiatric diagnostic examinations (CPT codes or 90792). CPT code may be reported with other psychiatric services or evaluation and management services only if a complete neurobehavioral status exam is performed. If a mini-mental status examination is performed by a physician, it is included in the evaluation and management service. 2. CPT codes describe psychological testing differing by method of performance and interpretation. Two or more codes from this code range may be reported on the same date of service if and only if the differing testing techniques are utilized for different psychological tests. Similarly, CPT codes describe neuropsychological testing differing by method of performance and interpretation. Two or more codes from this latter code range may be reported on the same date of service if and only if the differing testing techniques are utilized for different neuropsychological tests. 3. The psychiatric diagnostic interview examination (CPT codes 90791, 90792) and psychological/ neuropsychological testing (CPT codes 96101, 96118) must be distinct services. CPT Manual instructions permit physicians to integrate other sources of clinical data into the report that is generated for CPT codes or Since the procedures described by CPT codes and are timed procedures, physicians should be careful to avoid reporting time for duplicating information included in the psychiatric diagnostic interview examination and report. 4. A physician may report CPT codes (psychological testing...) or (neuropsychological testing...) only if the physician personally administers at least one test to the patient.

17 5. Central nervous system (CNS) assessment/test CPT codes (e.g., , 96118, should not be reported for tests that are reportable as part of an evaluation and management service when performed. In order to report a CNS assessment/test CPT code, the test cannot be self-administered. It must be administered by a physician, psychologist, technician, or computer as required by the code descriptor of the reported CPT code. The test must assess CNS function (e.g., psychological health, aphasia, neuropsychological health) per requirements of the CNS assessment/test CPT code descriptors. The assessment must utilize tests described by the code descriptor or other tests not available in the public domain. Comments Revision History Date Revision 10/01/2014 This Coding Guideline replaces all previous Coding Guidelines to comply with ICD-10-CM based on Change Request The effective date of this Coding Guideline is based on date of service. 11/27/ Based on an external reconsideration request CPT code was removed from the Coding Guidelines attachment. The effective date of this revision is for claims processed on or after November 27, 2013, for dates of service on or after October 14, /14/2013 Original Document formatted: 11/19/2013 (MB/et) 12/03/13(DA/et)